Director/PDMR Shareholding

Deltex Medical Group PLC
25 January 2008





                            Deltex Medical Group plc

                            Directors' Shareholdings


25 January 2008: Deltex Medical Group plc ('Deltex Medical' or the 'Company'),
the UK's leading haemodynamic monitoring company, announces that it has today
conditionally allotted a total of 413,746 new ordinary shares in the Company to
certain non-executive directors of the Company and a former director of the
Company at a price of 19.25 pence per share.



The three non-executive directors named below and a former director have elected
to take shares in lieu of a cash payment as remuneration for their services to
the Company.



The shares will rank pari passu with the existing issued shares of the Company.
This allotment is conditional on the appropriate authorities being received at
the next general meeting of the Company. Following the issue of these new
shares, subject to no changes, the Company will have a total of 92,901,653
ordinary shares in issue.



Following this conditional issue, the directors' beneficial interests will be as
follows:




Name of Director                    Current                Number     Holding of shares                 % of
                               shareholding       of new ordinary    following issue of      enlarged issued
                                            shares issued in lieu   new ordinary shares        share capital
                                                          of fees
Nigel Keen (1)                    4,255,114               162,338             4,417,452                 4.75
Dr Edwin Snape (2)                3,256,399               116,883             3,373,282                 3.63
Andy Hill                           179,334                     -               179,334                 0.19
Ewan Phillips                       977,156                     -               977,156                 1.05
George Flouty                       343,984                     -               343,984                 0.37
Sir Duncan Nichol                   108,961                91,169               200,130                 0.21

Total                             9,120,948               370,390             9,491,338                10.21





(1) Includes 589,700 shares held as trustee and executor of Pauline Thomas 
    Charity Will Trust.



(2) Includes shares held as a director of New England Partners and
    associated companies.



For further information, please contact:-


Deltex Medical Group plc                         01243 774 837
Nigel Keen, Chairman
Andy Hill, Chief Executive
Ewan Phillips, Finance Director



Charles Stanley Securities (Nominated Adviser)   020 7149 6000
Philip Davies
Russell Cook




                      This information is provided by RNS
            The company news service from the London Stock Exchange